Secondary spontaneous pneumothorax in patients with sarcoma treated with Pazopanib, a case control study.

Bruce SabathHasan A MuhammadAmulya BalaganiDavid E OstErik VakilTahreem AhmedMacarena R VialHoriana B Grosu

Published in: BMC cancer (2018)

Pazopanib does not increase the risk of pneumothorax in patients with sarcoma and evidence of metastatic disease to the chest. Presence of cavitary lung nodules/masses and the presence of pleural-based nodules/masses were found to be risk factors for pneumothorax.

Keyphrases

squamous cell carcinoma
contrast enhanced
fine needle aspiration
small cell lung cancer
ultrasound guided
metastatic renal cell carcinoma
contrast enhanced ultrasound
magnetic resonance imaging